/Autologous Biologics Market 2021-2026 In-Depth Analysis with Top Key Players: Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics
Autologous Biologics Market 2021-2026 In-Depth Analysis with Top Key Players: Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics
infinityMay 22, 2021 1
Global Autologous Biologics Market study by Infinity Business Insights highlights the key driving and restraining forces for this market and also provides a detailed study of the future trends and developments of the market. It then attracts the strangest insights of this business and creates a forecast for the period 2021 to 2026.
The Autologous Biologics market size portion covers market revenue along with the market’s historical growth and future projections. The analysis of development activities and new solutions in the report will strengthen players’ geographical scope as well as help them expand their market dynamics and increase
Share this article
Share this article
ResearchAndMarkets.com s offering.
Cell Therapy Global Market Report 2020-30: COVID 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global cell therapy market.
Major players in the cell therapy market are Fibrocell Science Inc., JCR Pharmaceuticals Co. Ltd., PHARMICELL Co. Ltd., Osiris Therapeutics Inc., MEDIPOST, Vericel Corporation, Anterogen Co. Ltd., Kolon TissueGene Inc., Stemedica Cell Technologies Inc. and AlloCure.
The global cell therapy market is expected to decline from $7.31 billion in 2019 to $7.2 billion in 2020 at a compound annual growth rate (CAGR) of -1.54%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupte